Archives of Disease in Childhood, Vol 75, 498-501, Copyright © 1996 by Archives of Disease in Childhood.

PAPERS

Relationship between disease severity and inflammatory markers in cystic fibrosis

DY Koller, M Gotz, C Wojnarowski and I Eichler
Division of Allergy and Pulmonology, University Children's Hospital, Vienna, Austria.

To evaluate the clinical use of measuring neutrophil, lymphocyte, and eosinophil activities, serum myeloperoxidase (MPO), soluble interleukin- 2 receptors (sIL-2R), and eosinophil cationic protein (ECP) were measured in 98 patients with cystic fibrosis and in 85 healthy children. Serum concentrations of MPO, sIL-2R, and ECP were increased in patients with cystic fibrosis (median 807 micrograms/l, 4452 pg/ml, 48.8 micrograms/l, respectively) compared with the controls (median 319 micrograms/l, 2743 pg/ml, 9.4 micrograms/l). ECP concentrations, but not serum MPO or sIL-2R, were significantly related to disease severity assessed by the Shwachman-Kulczycki score and by pulmonary function (forced expiratory volume in one second % predicted). Neither ECP nor sIL-2R was influenced by Pseudomonas aeruginosa infection, acute pulmonary exacerbation, or atopy. Serum MPO, however, was strongly correlated with acute pulmonary exacerbation. In the light of these findings the measurement of serum ECP might thus be used for clinical monitoring and for assessing disease severity in cystic fibrosis. The measurement of serum MPO and sIL-2R did not correlate with the disease severity.

This article has been cited by other articles:

				A. J. Sloane, R. A. Lindner, S. S. Prasad, L. T. Sebastian, S. K. Pedersen, M. Robinson, P. T. Bye, D. W. Nielson, and J. L. Harry Proteomic Analysis of Sputum from Adults and Children with Cystic Fibrosis and from Control Subjects Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1416 - 1426. [Abstract] [Full Text] [PDF]

				D Foell, S Seeliger, T Vogl, H-G Koch, H Maschek, E Harms, C Sorg, and J Roth Expression of S100A12 (EN-RAGE) in cystic fibrosis Thorax, July 1, 2003; 58(7): 613 - 617. [Abstract] [Full Text] [PDF]

				C A. Hart and C. Winstanley Persistent and aggressive bacteria in the lungs of cystic fibrosis children Br. Med. Bull., March 1, 2002; 61(1): 81 - 96. [Abstract] [Full Text] [PDF]

				R. L Smyth, N. M Croft, U. O'Hea, T. G Marshall, and A. Ferguson Intestinal inflammation in cystic fibrosis Arch. Dis. Child., May 1, 2000; 82(5): 394 - 399. [Abstract] [Full Text]